Advertisement

Composite risk factors predict survival after transplantation for congenital heart disease

      Objective(s)

      Previous studies have shown that individual risk factors are poor predictors of mortality after heart transplantation in patients with congenital heart disease. We developed composite risk factor groups to better predict mortality after cardiac transplantation.

      Methods

      We conducted a cross-sectional retrospective analysis of all heart transplants performed for congenital heart disease at a single congenital heart transplant center between 1996 and 2011. Patient, procedural, and hospital course data were obtained through a review of medical records. Univariate analyses were performed using the Fisher exact test for categorical data and the Mann-Whitney U test for continuous variables. Overall mortality was examined using Kaplan-Meier estimates for univariate analysis and Cox regression analysis for multivariate analysis. A comparison of patients with functional single ventricles (SVs) versus biventricular (BV) hearts was performed. Mean follow-up duration for the whole group was 51 ± 43 months (median, 43 months).

      Results

      Forty-six patients underwent heart transplantation during the study period. Mean age at transplant was 9.0 ± 9.1 years; 45% (n = 21) were in the SV group and 55% (n = 25) were in the BV group. The SV group had significantly more previous sternotomies (P = .006) and longer bypass times (266 ± 78 vs 207 ± 64 minutes; P = .001). High panel-reactive antibody levels (>10%) were also more common in the SV group (38% vs 13%; P = .08). Overall hospital mortality was 4.3% (n = 2, both SVs). There was no significant difference in operative mortality (10% SV vs 0% BV; P = .20) or major morbidity (33% SV vs 44% BV; P = .51) between the 2 groups. High-risk groups identified by univariate analysis were patients with an SV diagnosis + dialysis (P < .0005), SV + mechanical assist device (VAD)/extracorporeal membrane oxygenation (ECMO) (P = .026), or VAD/ECMO + renal insufficiency (P = .006)/VAD/ECMO + dialysis (P < .0005), and SV + reoperation (P = .016). By multivariate analysis, preoperative renal insufficiency (P = .038) and the composite SV + dialysis (P = .005) were predictors of overall mortality. Although survival at 2 years was lower in the SV cohort (73% vs 96%; P = .16), this benefit was not apparent (63% vs 69%) at late follow-up.

      Conclusions

      Preoperative renal insufficiency and SV + dialysis are strong predictors of overall mortality and identify high-risk congenital heart transplant recipients. Although individual risk factors may not predict survival, a composite of factors may be more useful in identifying the high-risk recipient.

      CTSNet classification

      Abbreviations and Acronyms:

      BIVAD (biventricular assist device), BV (biventricular), CHD (congenital heart disease), ECMO (extracorporeal membrane oxygenation), PRA (panel-reactive antibody), SV (single ventricle), UNOS (United Network of Organ Sharing), VAD (ventricular assist device)
      To read this article in full you will need to make a payment

      References

        • Castaneda A.
        Congenital heart disease: a surgical-historical perspective.
        Ann Thorac Surg. 2005; 79: S2217-S2220
        • Chen J.M.
        • Davies R.R.
        • Mital S.R.
        • Mercando M.L.
        • Addonizio L.J.
        • Pinney S.P.
        • et al.
        Trends and outcomes in transplantation for complex congenital heart disease: 1984 to 2004.
        Ann Thorac Surg. 2004; 78 (discussion 1352-61): 1352-1361
        • Kirk R.
        • Edwards L.B.
        • Aurora P.
        • Taylor D.O.
        • Christie J.
        • Dobbels F.
        • et al.
        Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric heart transplantation report–2008.
        J Heart Lung Transplant. 2008; 27: 970-977
        • Russo M.J.
        • Davies R.R.
        • Sorabella R.A.
        • Martens T.P.
        • George I.
        • Cheema F.H.
        • et al.
        Adult-age donors offer acceptable long-term survival to pediatric heart transplant recipients: an analysis of the United Network of Organ Sharing database.
        J Thorac Cardiovasc Surg. 2006; 132: 1208-1212
        • Huang J.
        • Trinkaus K.
        • Huddleston C.B.
        • Mendeloff E.N.
        • Spray T.L.
        • Canter C.E.
        Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics.
        J Heart Lung Transplant. 2004; 23: 716-722
        • Davies R.R.
        • Russo M.J.
        • Mital S.
        • Martens T.M.
        • Sorabella R.S.
        • Hong K.N.
        • et al.
        Predicting survival among high-risk pediatric cardiac transplant recipients: an analysis of the United Network for Organ Sharing database.
        J Thorac Cardiovasc Surg. 2008; 135 (e1-2): 147-155
        • Tang L.
        • Du W.
        • L'Ecuyer T.J.
        Perioperative renal failure in pediatric heart transplant recipients: outcome and risk factors.
        Pediatr Transplant. 2011; 15: 430-436
        • Sahney S.
        • Chinnock R.
        Management of infants and young children with combined heart and kidney failure.
        Pediatr Transplant. 2006; 10: 408-412
        • Groetzner J.
        • Kaczmarek I.
        • Mueller M.
        • Huber S.
        • Deutsch A.
        • Daebritz S.
        • et al.
        Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression.
        J Heart Lung Transplant. 2005; 24: 1787-1792
        • Mahle W.T.
        • Tresler M.A.
        • Edens R.E.
        • Rusconi P.
        • George J.F.
        • Naftel D.C.
        • et al.
        Allosensitization and outcomes in pediatric heart transplantation.
        J Heart Lung Transplant. 2011; 30: 1221-1227
        • Jacobs J.P.
        • Quintessenza J.A.
        • Boucek R.J.
        • Morell V.O.
        • Botero L.M.
        • Badhwar V.
        • et al.
        Pediatric cardiac transplantation in children with high panel reactive antibody.
        AnnThorac Surg. 2004; 78: 1703-1709
        • Everitt M.D.
        • Boyle G.J.
        • Schechtman K.B.
        • Zheng J.
        • Bullock E.A.
        • Kaza A.K.
        • et al.
        Early survival after heart transplant in young infants is lowest after failed single-ventricle palliation: a multi-institutional study.
        J Heart Lung Transplant. 2012; 31: 509-516
        • Lamour J.M.
        • Kanter K.R.
        • Naftel D.C.
        • Chrisant M.R.
        • Morrow W.R.
        • Clemson B.S.
        • et al.
        The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease.
        J Am Coll Cardiol. 2009; 54: 160-165
        • Bernstein D.
        • Naftel D.
        • Chin C.
        • Addonizio L.J.
        • Gamberg P.
        • Blume E.D.
        • et al.
        Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study.
        Circulation. 2006; 114: 273-280
        • Kanter K.R.
        • Mahle W.T.
        • Vincent R.N.
        • Berg A.M.
        • Kogon B.E.
        • Kirshbom P.M.
        Heart transplantation in children with a Fontan procedure.
        Ann Thorac Surg. 2011; 91 (discussion 829-30): 823-829
        • Jayakumar K.A.
        • Addonizio L.J.
        • Kichuk-Chrisant M.R.
        • Galantowicz M.E.
        • Lamour J.M.
        • Quaegebeur J.M.
        • et al.
        Cardiac transplantation after the Fontan or Glenn procedure.
        J Am Coll Cardiol. 2004; 44: 2065-2072
        • Fiser W.P.
        • Yetman A.T.
        • Gunselman R.J.
        • Fasules J.W.
        • Baker L.L.
        • Chipman C.W.
        • et al.
        Pediatric arteriovenous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation.
        J Heart Lung Transplant. 2003; 22: 770-777
        • Gajarski R.J.
        • Mosca R.S.
        • Ohye R.G.
        • Bove E.L.
        • Crowley D.C.
        • Custer J.R.
        • et al.
        Use of extracorporeal life support as a bridge to pediatric cardiac transplantation.
        J Heart Lung Transplant. 2003; 22: 28-34
        • Davies R.R.
        • Russo M.J.
        • Hong K.N.
        • O'Byrne M.L.
        • Cork D.P.
        • Moskowitz A.J.
        • et al.
        The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: an analysis of the United Network for Organ Sharing database.
        J Thorac Cardiovasc Surg. 2008; 135: 421-427.e1
        • Chen J.M.
        • Russo M.J.
        • Hammond K.M.
        • Mancini D.M.
        • Kherani A.R.
        • Fal J.M.
        • et al.
        Alternate waiting list strategies for heart transplantation maximize donor organ utilization.
        Ann Thorac Surg. 2005; 80: 224-228
        • Laks H.
        • Marelli D.
        • Fonarow G.C.
        • Hamilton M.A.
        • Ardehali A.
        • Moriguchi J.D.
        • et al.
        Use of two recipient lists for adults requiring heart transplantation.
        J Thorac Cardiovasc Surg. 2003; 125: 49-59
        • Bagshaw S.M.
        • George C.
        • Bellomo R.
        A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients.
        Nephrol Dial Transplant. 2008; 23: 1569-1574